Bachem Holding AG (SWX: BANB)
78.00
-1.35 (-1.70%)
Sep 4, 2024, 5:30 PM CET
Bachem Holding AG Company Description
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs).
It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services.
Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.
Bachem Holding AG
![Bachem Holding AG logo](https://img.stockanalysis.com/logos1/SW/BANB.png)
Country | Switzerland |
Founded | 1971 |
Industry | Chemicals |
Sector | Materials |
Employees | 2,009 |
CEO | Thomas Meier |
Contact Details
Address: Hauptstrasse 144 Bubendorf, 4416 Switzerland | |
Phone | 41 58 595 2021 |
Website | bachem.com |
Stock Details
Ticker Symbol | BANB |
Exchange | SIX Swiss Exchange |
Fiscal Year | January - December |
Reporting Currency | CHF |
ISIN Number | CH1176493729 |
SIC Code | 2833 |